Robert S Wallis

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Plasmodium Falciparum

Mycobacterium Tuberculosis

Multidrug Resistant

Top Venues

Antioxidants (Basel, Switzerland)

Nature reviews. Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Robert S Wallis, Anne O'Garra, Alan Sher, Andreas Wack
Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nature reviews. Immunology (2022)
Daniel Adon Mapamba, Elingarami Sauli, Lucy Mrema, Julieth Lalashowi, David Magombola, Joram Buza, Willyhelmina Olomi, Robert S Wallis, Nyanda Elias Ntinginya
Impact of N -Acetyl Cysteine (NAC) on Tuberculosis (TB) Patients-A Systematic Review. Antioxidants (Basel, Switzerland) 11 (11) (2022)
Robert S Wallis, Sibuse Ginindza, Trevor Beattie, Nishanee Arjun, Morongwe Likoti, Modulakgotla Sebe, Vinodh A Edward, Mohammed Rassool, Khatija Ahmed, Katherine Fielding, Bintou A Ahidjo, Mboyo D T Vangu, Gavin Churchyard
Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial. PloS one 17 (2) (2022)
Robert S Wallis, Caryn E Good, Mary A O'Riordan, Jeffrey L Blumer, Michael R Jacobs, J McLeod Griffiss, Amanda Healan, Robert A Salata
Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial. PloS one 13 (5) (2018)